Gilgamesh Pharma's last reported valuation, May 2022. Nothing priced has surfaced since.
- ·The complete investor list: 24 names
- ·Watch Gilgamesh Pharma: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Gilgamesh Pharma funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2026 | Seed Round | $2.3M | ▮ | ▮ |
| Mar 2026 | Later Stage VC | $60.0M | ▮ | ▮ |
| Jan 2026 | Early Stage VC | $6.1M | ▮ | ▮ |
Membership and data by Private Market View
Gilgamesh Pharma valuation
Gilgamesh Pharma's last reported valuation was $189 million in May 2022. No priced round, secondary trade or fund mark has surfaced since.
How much has Gilgamesh Pharma raised?
Gilgamesh Pharma has raised $136 million across 3 recorded rounds since 2026. The largest was a $6.1 million early-stage round in Jan 2026; the most recent was a $2.3 million seed round in Mar 2026.
Gilgamesh Pharma has filed 2 Form Ds with the SEC, most recently in Mar 2026 ($2.3 million sold to 3 investors).
Institutional holders and vehicles
In the last 12 months, 1 investment vehicle was formed to buy Gilgamesh Pharma shares, reporting $1.8 million sold to 25 investors, per SEC Form D filings (most recent Mar 2026).
How Gilgamesh Pharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Gilgamesh Pharma, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Gilgamesh Pharma
- What is Gilgamesh Pharma worth?
- Gilgamesh Pharma is valued at $188.5M as of Oct 2026. Gilgamesh Pharma's last reported valuation, May 2022. Nothing priced has surfaced since.
- How much has Gilgamesh Pharma raised?
- Gilgamesh Pharma has raised $135.8M in total funding across 3 recorded rounds.
- When did Gilgamesh Pharma last raise?
- Gilgamesh Pharma last raised in Mar 2026 (Seed Round), raising $2.3M.